Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds

Mar Drugs. 2018 Sep 4;16(9):313. doi: 10.3390/md16090313.

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by long-term airflow limitation. Early-onset COPD in non-smoker subjects is ≥60 years and in the elderly is often associated with different comorbidities. Cognitive impairment is one of the most common feature in patients with COPD, and is associated with COPD severity and comorbidities. Cognitive impairment in COPD enhances the assistance requirement in different aspects of daily living, treatment adherence, and effectual self-management.This review describes various bioactive compounds of natural marine sources that modulate different targets shared by both COPD and cognitive impairment and hypothesizes a possible link between these two syndromes.

Keywords: COPD; cognitive impairment; management strategy; marine bioactive compound; systems approaches.

Publication types

  • Review

MeSH terms

  • Aged
  • Aquatic Organisms / chemistry*
  • Biological Products / isolation & purification
  • Biological Products / therapeutic use*
  • Biomarkers / analysis
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / epidemiology
  • Cognitive Dysfunction / etiology
  • Cognitive Dysfunction / prevention & control*
  • Comorbidity
  • Humans
  • Incidence
  • Neuroprotective Agents / isolation & purification
  • Neuroprotective Agents / therapeutic use*
  • Pulmonary Disease, Chronic Obstructive / epidemiology*
  • Risk Factors

Substances

  • Biological Products
  • Biomarkers
  • Neuroprotective Agents